Mouse Anti-ILF2 Recombinant Antibody (CBYY-I1215) (CBMAB-I2384-YY)

Xu, J., Li, F., Zhang, J., Wang, L., Liu, X., Xue, W., ... & Cui, Y. (2023). The interleukin enhancer binding factor-2 (ILF2) gene in Penaeus japonicus shrimp: cloning, tissue distribution, and antiviral effects. Aquaculture International, 1-15.

Zhang, H., Che, Y., Xuan, B., Wu, X., & Li, H. (2022). Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2). Bioengineered, 13(4), 8785-8797.

Wei, L., Yang, C., Wang, G., Li, K., Zhang, Y., Guan, H., ... & Zhong, C. (2021). Interleukin enhancer binding factor 2 regulates cell viability and apoptosis of human brain vascular smooth muscle cells. Journal of Molecular Neuroscience, 71, 225-233.

Zhang, X., Bustos, M. A., Gross, R., Ramos, R. I., Takeshima, T. L., Mills, G. B., ... & Hoon, D. S. (2021). Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma. Clinical and Translational Medicine, 11(10), e608.

Cheung, Y., Wu, Z., Garcia-Barcelo, M. M., Tam, P. K. H., Ma, A. C. H., & Lui, V. C. H. (2021). Deletion of interleukin enhancer binding factor 2 (ILF2) resulted in defective biliary development and bile flow blockage. Journal of Pediatric Surgery, 56(2), 352-359.

Shiu, T. Y., Lin, H. H., Shih, Y. L., Feng, A. C., Huang, H. H., Huang, T. Y., ... & Hsieh, T. Y. (2021). CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation. Life Sciences, 284, 119708.

Jiang, X., Zhang, X., Ren, C., Ruan, Y., Lu, Y., Yuan, L., ... & Chen, T. (2021). Interleukin-2 enhancer binding factor 2 (ILF2) in pacific white shrimp (Litopenaeus vannamei): Alternatively spliced isoforms with different responses in the immune defenses against vibrio infection. Developmental & Comparative Immunology, 118, 103975.

Cui, X., Qian, P., Rao, T., Wei, Y., Zhao, F., Zhang, H., ... & Li, X. (2019). Cellular interleukin enhancer-binding factor 2, ILF2, inhibits Japanese Encephalitis virus replication in vitro. Viruses, 11(6), 559.

Jin, J., Wang, W., Ai, S., Liu, W., Song, Y., Luo, Z., ... & Wu, J. (2019). Enterovirus 71 represses interleukin enhancer-binding factor 2 production and nucleus translocation to antagonize ILF2 antiviral effects. Viruses, 12(1), 22.

Jin, Z., Xu, L., Zhang, L., Zhao, M., Li, D., Ye, L., ... & Chen, B. (2018). Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses. American journal of translational research, 10(6), 1677.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols